Kenneth McLeod is a PHD teaching professor at a major university and an international expert on bio electronic medicine. He not only believes in Biel’s tech but has performed invaluable services such as research expertise and marketing videos demonstrating and explaining Actipatch technology and mechanism of action in a clear and understandable way lending to vital legitimacy in the academic community.
BioElectronics like all small developmental stage companies reimbursed invaluable credentialed consulting experts in shares because cash flow needs to be redirected back into the company.
Do you think McLeod should work for nothing?
What’s your point exactly?
BIEL
All my opinions are mine alone please make investment decisions based on your own DD.